Actively Recruiting
Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project
Led by Istituto Ortopedico Rizzoli · Updated on 2025-05-30
260
Participants Needed
1
Research Sites
498 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Experimental study with biological material : case series review of clinical and histological data
CONDITIONS
Official Title
Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with undifferentiated round cell sarcomas treated from 01 January 1983 and all new patients will be included.
- Clinical and outcome information available.
- Histological slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to perform the histology analysis/frozen tissue representative of the tumor available.
You will not qualify if you...
- Diagnosis different from undifferentiated round cell sarcomas
- Patient with no clinical or outcome information available
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCs Istituto Ortopedico Rizzoli
Bologna, BO, Italy, 40136
Actively Recruiting
Research Team
E
Emanuela Palmerini, MD
CONTACT
M
Marco Gambarotti, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here